PROTAC CDK9 degrader-2


CAS No. : 2435721-30-3

2435721-30-3
Price and Availability of CAS No. : 2435721-30-3
Size Price Stock
1mg $395 In-stock
5mg $990 In-stock
10mg $1585 In-stock
25mg $2950 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-112811
M.Wt: 748.74
Formula: C39H36N6O10
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 2435721-30-3 :

PROTAC CDK9 degrader-2 is a PROTAC degrader targeting CDK9, with an IC50 of 523 nM. PROTAC CDK9 degrader-2 selectively degrades CDK9 via the cereblon-dependent ubiquitin-proteasome pathway and inhibits the proliferation of cancer cells overexpressing CDK9. PROTAC CDK9 degrader-2 can be used for cancer research[1]. IC50 & Target:IC50: 17 μM (CDK9, MCF-7 cells)[1] In Vitro:PROTAC CDK9 degrader-2 (compound 11c, 1-30 μM, 24 h) selectively induces concentration-dependent, proteasome-dependent, and CRBN-dependent degradation of CDK9 and its downstream Mcl-1 protein in MCF-7 cells[1].
PROTAC CDK9 degrader-2 (72 h) selectively inhibits the proliferation of MCF-7 cells with overexpressed CDK9, with an IC50 of 17 μM, while its activity against L02 cells with low CDK9 expression is negligible[1].
PROTAC CDK9 degrader-2 (10-20 μM; 24 h) induces dose-dependent apoptosis in MCF-7 cells following incubation at concentrations of 10 μM and 20 μM for 24 h[1].
PROTAC CDK9 degrader-2 (1 μM; 1 h) potently inhibits the kinase activity of recombinant CDK9/CycT1, with an IC50 value of 523 nM[1].

Your information is safe with us.